HALSEY DRUG CO INC/NEW
10-Q, EX-27, 2000-11-13
PHARMACEUTICAL PREPARATIONS
Previous: HALSEY DRUG CO INC/NEW, 10-Q, 2000-11-13
Next: CHI ENERGY INC, 10-Q, 2000-11-13



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL CONDITION AT SEPTEMBER 30, 2000
(UNAUDITED) AND THE CONDENSED CONSOLIDATED STATEMENT OF INCOME FOR THE NINE
MONTHS ENDED SEPTEMBER 30, 2000 (UNAUDITED) AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER>                                     1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           3,333
<SECURITIES>                                         0
<RECEIVABLES>                                    5,467
<ALLOWANCES>                                        63
<INVENTORY>                                      3,112
<CURRENT-ASSETS>                                12,610
<PP&E>                                          14,296
<DEPRECIATION>                                  11,345
<TOTAL-ASSETS>                                  18,532
<CURRENT-LIABILITIES>                           10,832
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           149
<OTHER-SE>                                    (49,264)
<TOTAL-LIABILITY-AND-EQUITY>                    18,532
<SALES>                                         16,903
<TOTAL-REVENUES>                                16,903
<CGS>                                           13,965
<TOTAL-COSTS>                                   13,965
<OTHER-EXPENSES>                                 5,857
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               4,694
<INCOME-PRETAX>                                (7,557)
<INCOME-TAX>                                       296
<INCOME-CONTINUING>                            (7,261)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (7,261)
<EPS-BASIC>                                     (0.50)
<EPS-DILUTED>                                   (0.50)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission